Results 301 to 310 of about 25,999 (347)
Some of the next articles are maybe not open access.
Rhynchophylline Attenuates Neurotoxicity in Tourette Syndrome Rats
Neurotoxicity Research, 2019Tourette syndrome (TS) is a chronic neuropsychiatric disorder with clinical manifestations of involuntary and repeated muscle twitching and vocal twitching. The drugs used to treat TS are relatively limited. The aim of this study was to investigate the effects of rhynchophylline (RH) and the underlying mechanism in 1-(2,5-dimethoxy-4-iodophenyl)-2 ...
Long, Hongyan +3 more
openaire +2 more sources
Neurotoxic Syndrome Associated with Risperidone and Fluvoxamine
Annals of Pharmacotherapy, 2002OBJECTIVE: To report a case of a neurotoxic syndrome in a patient undergoing concomitant treatment with risperidone and fluvoxamine. CASE REPORT: A 24-year-old African American woman hospitalized for psychosis was unresponsive to risperidone. Because of obsessive symptoms, low doses of fluvoxamine were added to her treatment regimen. Within 2 days, she
Roy R, Reeves +2 more
openaire +2 more sources
Bracken thiaminase-mediated neurotoxic syndromes
Botanical Journal of the Linnean Society, 1976The toxicity of bracken (Pteridium aquilinum (L.) Kuhn) to animals is complicated because this plant elaborates more than one type of agent harmful to livestock. An enzyme, thiaminase I, which destroys thiamine, is responsible for the neurotoxic syndrome.
openaire +1 more source
Neurotoxic Syndromes and Occupational Exposure to Solvents
Environmental Research, 1993Neurotoxic syndromes due to occupational solvent exposure present a worldwide health problem, the magnitude of which varies from country to country. Apart from the relatively clear-cut exposure-effect relationships in acute solvent intoxications, those caused by long-term, low-level occupational exposure to solvents are more difficult to detect ...
openaire +2 more sources
Posterior reversible encephalopathy syndrome: A rare neurotoxicity after capecitabine
Journal of Oncology Pharmacy Practice, 2020Background Posterior reversible encephalopathy syndrome (PRES) is a condition characterized by seizures, headache, visual disturbances, paresis, nausea and altered mental status. Risk factors include hypertension, eclampsia/pre-eclampsia, infection/sepsis, transplantation (allograft, bone marrow and solid organ) and immunosuppression, especially in ...
Manlio Monti +5 more
openaire +2 more sources
Evaluation of Neurotoxic Syndromes
1995Diagnosis and management of patients with neurotoxic syndromes can best be carried out by a specialized team of health care professionals. The respective contributions from physicians and neuropsychologists will obviously depend on the circumstances of toxic exposure.
openaire +1 more source
The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT)
Pharmacopsychiatry, 1989Though the acute complications of lithium toxicity involving the central nervous system have been known for more than 70 years, it is only recently that the longlasting sequelae of lithium intoxication have come to be discussed at length; about fifty-five cases have been reported so far.
openaire +2 more sources
Neuropsychological toxicology: Identification and assessment of neurotoxic syndromes
Archives of Clinical Neuropsychology, 1987Neuropsychological toxicology, or, more commonly, "neurobehavioral toxicology" is the study of how naturally or industrially produced nervous system poisons effect neuropsychological functioning. Research of this sort has been widely disseminated in European and Scandinavian medical literature during the past two decades but is only just beginning to ...
openaire +2 more sources
[Acute methotrexate-related neurotoxicity and pseudo-stroke syndrome].
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie, 2018Treatment of acute lymphoblastic leukemia requires high-dose systemic and/or intrathecal methotrexate to prevent and/or treat central nervous system disorders. Acute neurotoxicity of methotrexate, of unknown etiopathogenesis, is characterized by the polymorphism of clinical manifestations, responsible for a potentially harmful diagnostic delay in these
V, Deneux +5 more
openaire +2 more sources
Organophosphorus poisoning and intermediate neurotoxic syndrome.
The Journal of the Association of Physicians of India, 1990Very few cases of the "intermediate neurotoxic syndrome", a type of neurotoxic effect or organophosphate compound have been reported in the literature. We are reporting a case that developed the clinical features of such type of neurotoxic effect after 55 hours of taking the organophosphorus compound.
K K, Samal, C S, Sahu
openaire +1 more source